These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
6. Intellectual property as a foundation for funding. Meltzer SL; Marks MS; McCormick JT Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588 [No Abstract] [Full Text] [Related]
7. Biotech IPOs--flop or pop? Jacobs T Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641 [No Abstract] [Full Text] [Related]
8. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
9. Chasing biotech, state by state--winners and losers. Wilan KH Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143 [No Abstract] [Full Text] [Related]
10. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
11. Biotech holds its own in Q2. Lawrence S Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634 [No Abstract] [Full Text] [Related]
12. A counselor's dose of preventive medicine. Redlick D; Kapner V Nat Biotechnol; 2002 Jul; 20 Suppl():BE51-3. PubMed ID: 12089589 [No Abstract] [Full Text] [Related]
13. VC funding hits high in Q1. Lawrence S Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825 [No Abstract] [Full Text] [Related]
14. Mixed results in Q1. Lawrence S Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059 [No Abstract] [Full Text] [Related]
15. Writing your business plan. Cohen L Nat Biotechnol; 2002 Jul; 20 Suppl():BE33-5. PubMed ID: 12089584 [No Abstract] [Full Text] [Related]
17. Filters for preparing to meet a venture capitalist. Christoffersen R Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981 [No Abstract] [Full Text] [Related]
18. Convincing a venture capitalist to invest in your idea. Dooley JF; Dooley JF Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980 [No Abstract] [Full Text] [Related]
19. Napster case spills into biotech sector. Bouchie A Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189 [No Abstract] [Full Text] [Related]
20. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related] [Next] [New Search]